Loading…
Based on limited metadata, this FDA Warning Letter issued to United Exchange Corporation on March 6, 2019, concerns drug products and represents a formal regulatory action by the FDA. Without access to the full letter text or specific subject line, the exact nature of the violations cannot be determined from the available information. The warning falls under FDA's drug regulation authority, though the specific issuing office and violation count are not documented in the metadata provided. To understand the particular compliance issues cited, the complete Warning Letter would need to be reviewed.